The epidermal growth factor receptor (EGF-R) plays an important role in development and cell differentiation, and homologues of EGF-R have been identified in a broad range of vertebrate and invertebrate organisms. This work concerns the functional characterization of SER, the EGF-R-like molecule previously identified in the helminth parasite Schistosoma mansoni The epidermal growth factor receptor (EGF-R) 1 is a major key mediator of cell communication during animal development and homeostasis. EGF-R was the first receptor tyrosine kinase to be cloned (1), and its structure and activation pathways have been studied extensively. EGF-R represents the archetype of receptor tyrosine kinase with an extracellular ligand-binding part with two cysteine-rich repeats and an intracellular domain containing tyrosine kinase activity (2). In mammals, four isoforms of EGF-R have been characterized (EGF-R/ErbB-1, HER2/ErbB-2, HER3/ErbB-3, and HER4/ ErbB-4), and a number of different ligands, including epidermal growth factor (EGF)-like molecules, can selectively bind each isoform (3). Ligand binding activates the receptor by inducing the formation of homo-heterodimers. Dimerization triggers trans-phosphorylation and subsequent autophosphorylation of receptor molecules on tyrosine residues that provide docking sites for diverse effector and adaptor proteins. These partners (Grb2/Sos, p85-PI3K, PLC␥, and JAK) are active in different signal transduction cascades, such as the mitogenactivated protein kinase (MAPK), phosphoinositol 3-kinase, antiapoptotic kinase Akt, and several transcriptional regulatory pathways (reviewed in Ref. 4). Different homodimer-heterodimer combinations formed by EGF-R family members drive a complex signaling network within the MAPK pathway. The ERK pathway is the most recurrent and is mainly responsible for the mitogenic action of EGF receptors. Dysregulation of EGF-R signaling is therefore strongly oncogenic, and the direct implication of EGF-R isoforms in various cancers has been widely demonstrated. For this reason, EGF-R currently represents one of the major drug targets in human cancer therapy (5).In invertebrates, EGF-R isoforms appeared to be expressed in more limited numbers. A single isoform has been characterized in Caenorhabditis elegans (LET-23) (6) as well as in Drosophila melanogaster (DER) (7,8). A single cognate ligand (LIN-3) would be present in the worm (9), and four distinct cognate ligands (Vein, Gurken, Spitz, and Argos) would be present in the fly (10). These observations indicated that the EGF-R signaling module has grown in complexity from invertebrates to mammals. However, except for C. elegans and D. melanogaster models, few data are available at present about the role of the EGF-R family in invertebrate development.SER, the Schistosoma mansoni EGF-R homologue, is one of the three receptor tyrosine kinases that have been characterized in this trematode parasite (11,12). SER is present predominantly in schistosome muscles, suggesting that it could